Symbols / MTLS Stock $5.30 -0.19% Materialise NV

Technology • Software - Application • Belgium • NMS
MTLS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Technology
Industry Software - Application
CEO Ms. Brigitte de Vet-Veithen
Exch · Country NMS · Belgium
Market Cap 309.87M
Enterprise Value 242.17M
Income 7.72M
Sales 267.63M
FCF (ttm) -1.32M
Book/sh 5.11
Cash/sh 2.27
Employees —
Insider 10d —
IPO Jun 25, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 35.33
Forward P/E 20.58
PEG 1.26
P/S 1.16
P/B 1.04
P/C —
EV/EBITDA 7.90
EV/Sales 0.91
Quick Ratio 2.06
Current Ratio 2.43
Debt/Eq 24.70
LT Debt/Eq —
EPS (ttm) 0.15
EPS next Y 0.26
EPS Growth 112.80%
Revenue Growth 6.80%
EPS Gr Q/Q 112.80%
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-19
ROA 1.37%
ROE 3.06%
ROIC —
Gross Margin 57.15%
Oper. Margin 4.43%
Profit Margin 2.88%
Shs Outstand 58.47M
Shs Float 23.83M
Insider Own 5.30%
Instit Own 14.05%
Short Float 1.66%
Short Ratio 4.89
Short Interest 389.90K
52W High 6.80
vs 52W High -22.06%
52W Low 4.78
vs 52W Low 10.88%
Beta 1.20
Impl. Vol. 6.25%
Rel Volume 0.80
Avg Volume 100.73K
Volume 80.34K
Target (mean) $8.78
Tgt Median $8.20
Tgt Low $8.18
Tgt High $9.95
# Analysts 3
Recom None
Prev Close $5.31
Price $5.30
Change -0.19%
About

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.78
Mean price target
2. Current target
$5.30
Latest analyst target
3. DCF / Fair value
$-0.41
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.30
Low
$8.18
High
$9.95
Mean
$8.78

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-04-24 init Cantor Fitzgerald — → Overweight $10
2023-04-28 main Lake Street — → Buy $12
2023-02-15 main Lake Street — → Buy $14
2021-10-20 init JP Morgan — → Overweight $28
2021-09-02 init Stifel — → Buy $30
2021-08-09 init Lake Street — → Buy $30
2021-03-10 up Bryan Garnier Neutral → Buy $43
2020-04-07 down Piper Sandler Overweight → Neutral $15
2020-01-10 down Keybanc Overweight → Sector Weight $20
2017-08-11 main Credit Suisse — → Outperform $14
2016-09-07 main Keybanc — → Overweight $10
2015-11-16 main Piper Sandler — → Overweight $9
2015-08-12 main Piper Sandler — → Overweight $10
2015-08-05 main Pacific Crest — → Overweight $11
2015-07-06 down KBC Partners Accumulate → Hold —
2014-10-07 init Canaccord Genuity — → Buy $15
2014-08-06 init KBC Partners — → Accumulate $14
News
RSS: Latest MTLS news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
266.76
+4.15%
256.13
+10.39%
232.02
+12.93%
205.45
Operating Revenue
266.76
+4.15%
256.13
+10.39%
232.02
+12.93%
205.45
Cost Of Revenue
115.94
+4.45%
111.00
+7.50%
103.25
+18.31%
87.28
Reconciled Cost Of Revenue
102.57
+4.57%
98.08
+8.88%
90.08
+21.52%
74.13
Gross Profit
150.82
+3.92%
145.13
+12.71%
128.77
+8.97%
118.17
Operating Expense
141.39
+8.69%
130.09
-1.68%
132.32
+25.09%
105.78
Research And Development
44.40
+16.54%
38.10
+1.41%
37.57
+39.70%
26.89
Selling General And Administration
96.15
+6.55%
90.24
-2.98%
93.02
+19.89%
77.59
Selling And Marketing Expense
10.97
+5.14%
10.44
-11.57%
11.80
+76.04%
6.70
General And Administrative Expense
85.18
+6.73%
79.81
-1.73%
81.22
+14.58%
70.88
Salaries And Wages
78.02
+7.48%
72.60
-3.17%
74.97
+25.72%
59.63
Other Gand A
7.15
-0.79%
7.21
+15.56%
6.24
-44.52%
11.25
Other Operating Expenses
-6.40
-6.74%
-5.99
+6.11%
-6.38
-17.96%
-5.41
Total Expenses
257.33
+6.74%
241.09
+2.34%
235.58
+22.02%
193.06
Operating Income
9.43
-37.29%
15.04
+523.25%
-3.55
-128.67%
12.39
Total Operating Income As Reported
9.43
+67.86%
5.62
+295.65%
-2.87
-123.51%
12.22
EBITDA
37.20
+23.62%
30.09
+28.40%
23.44
-36.17%
36.72
Normalized EBITDA
35.09
-13.81%
40.72
+107.50%
19.62
-40.99%
33.25
Reconciled Depreciation
21.76
+0.89%
21.57
-4.43%
22.57
+9.83%
20.55
EBIT
15.44
+81.13%
8.52
+880.78%
0.87
-94.63%
16.17
Total Unusual Items
2.11
+119.82%
-10.62
-378.58%
3.81
+9.95%
3.47
Total Unusual Items Excluding Goodwill
2.11
+119.82%
-10.62
-378.58%
3.81
+9.95%
3.47
Special Income Charges
0.00
+100.00%
-9.42
-1482.97%
0.68
+484.75%
-0.18
Other Special Charges
—
5.19
+861.97%
-0.68
—
Impairment Of Capital Assets
0.00
-100.00%
4.23
0.00
-100.00%
0.18
Write Off
—
—
0.00
0.00
Net Income
13.44
+99.88%
6.72
+416.63%
-2.12
-116.14%
13.15
Pretax Income
14.14
+108.79%
6.77
+674.87%
-1.18
-108.58%
13.74
Net Non Operating Interest Income Expense
2.60
+10.21%
2.36
+264.07%
-1.44
+32.35%
-2.13
Interest Expense Non Operating
1.30
-25.81%
1.75
-14.46%
2.05
-15.93%
2.44
Net Interest Income
2.60
+10.21%
2.36
+264.07%
-1.44
+32.35%
-2.13
Interest Expense
1.30
-25.81%
1.75
-14.46%
2.05
-15.93%
2.44
Interest Income Non Operating
4.25
-4.45%
4.45
+234.08%
1.33
+102.43%
0.66
Interest Income
4.25
-4.45%
4.45
+234.08%
1.33
+102.43%
0.66
Other Income Expense
2.11
+119.82%
-10.62
-378.58%
3.81
+9.95%
3.47
Other Non Operating Income Expenses
—
—
—
0.72
Gain On Sale Of Security
2.11
+274.48%
-1.21
-138.53%
3.13
-14.07%
3.65
Tax Provision
0.73
+839.74%
0.08
-92.00%
0.97
+64.97%
0.59
Tax Rate For Calcs
0.00
+350.10%
0.00
-95.39%
0.00
+481.04%
0.00
Tax Effect Of Unusual Items
0.11
+189.21%
-0.12
-112.83%
0.95
+538.84%
0.15
Net Income Including Noncontrolling Interests
13.41
+100.24%
6.70
+410.96%
-2.15
-116.38%
13.14
Net Income From Continuing Operation Net Minority Interest
13.44
+99.88%
6.72
+416.63%
-2.12
-116.14%
13.15
Net Income From Continuing And Discontinued Operation
13.44
+99.88%
6.72
+416.63%
-2.12
-116.14%
13.15
Net Income Continuous Operations
13.41
+100.27%
6.69
+410.92%
-2.15
-116.38%
13.14
Minority Interests
0.03
+11.11%
0.03
-6.90%
0.03
+222.22%
0.01
Normalized Income
11.44
-33.59%
17.22
+445.63%
-4.98
-150.67%
9.83
Net Income Common Stockholders
13.44
+99.88%
6.72
+416.63%
-2.12
-116.14%
13.15
Diluted EPS
0.23
+109.09%
0.11
+375.00%
-0.04
—
Basic EPS
0.23
+109.09%
0.11
+375.00%
-0.04
—
Basic Average Shares
59.07
+0.00%
59.07
+0.01%
59.06
—
Diluted Average Shares
59.10
+0.03%
59.09
+0.04%
59.06
—
Diluted NI Availto Com Stockholders
13.44
+99.88%
6.72
+416.63%
-2.12
-116.14%
13.15
Amortization
8.39
-3.07%
8.66
-7.86%
9.40
+26.99%
7.40
Amortization Of Intangibles Income Statement
8.39
-3.07%
8.66
-7.86%
9.40
+26.99%
7.40
Depreciation Amortization Depletion Income Statement
8.39
-3.07%
8.66
-7.86%
9.40
+26.99%
7.40
Depreciation And Amortization In Income Statement
8.39
-3.07%
8.66
-7.86%
9.40
+26.99%
7.40
Depreciation Income Statement
—
—
—
2.99
Earnings From Equity Interest
—
—
0.00
0.00
Other Taxes
-1.25
+8.38%
-1.36
-53.33%
-0.89
-18.90%
-0.75
Provision For Doubtful Accounts
0.10
-78.79%
0.45
+214.87%
-0.39
-772.41%
0.06
Total Other Finance Cost
0.35
+3.85%
0.34
-53.31%
0.72
+106.86%
0.35
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
396.34
-0.07%
396.63
-3.56%
411.26
-0.52%
413.41
Current Assets
190.51
-7.73%
206.47
-4.60%
216.41
-16.05%
257.80
Cash Cash Equivalents And Short Term Investments
102.30
-19.81%
127.57
-9.44%
140.87
-28.14%
196.03
Cash And Cash Equivalents
102.30
-19.81%
127.57
-9.44%
140.87
-28.14%
196.03
Cash Equivalents
4.98
-37.48%
7.97
-93.06%
114.84
+3565.46%
3.13
Cash Financial
97.32
-18.63%
119.61
+359.53%
26.03
-86.51%
192.90
Receivables
59.72
+3.87%
57.50
+5.03%
54.75
+21.05%
45.23
Accounts Receivable
53.05
+0.67%
52.70
+3.24%
51.04
+22.87%
41.54
Gross Accounts Receivable
53.72
+0.40%
53.51
+4.01%
51.44
+20.15%
42.81
Allowance For Doubtful Accounts Receivable
-0.67
+17.35%
-0.81
-101.75%
-0.40
+68.58%
-1.27
Other Receivables
1.50
-1.18%
1.52
-12.49%
1.74
+11.78%
1.55
Taxes Receivable
5.17
+57.59%
3.28
+66.84%
1.97
-7.79%
2.13
Inventory
16.40
+0.03%
16.40
+6.21%
15.44
+42.94%
10.80
Raw Materials
9.01
-0.60%
9.06
+13.62%
7.97
+27.68%
6.25
Work In Process
4.24
+4.10%
4.07
-12.02%
4.63
+94.13%
2.38
Finished Goods
3.16
-3.31%
3.27
+15.12%
2.84
+30.68%
2.17
Current Deferred Assets
5.30
+18.17%
4.49
+7.89%
4.16
+40.57%
2.96
Hedging Assets Current
0.00
-100.00%
0.14
-46.74%
0.26
-85.25%
1.77
Other Current Assets
6.78
+1723.66%
0.37
-60.59%
0.94
-7.54%
1.02
Total Non Current Assets
205.82
+8.23%
190.17
-2.40%
194.85
+25.22%
155.60
Net PPE
119.05
+15.02%
103.50
+0.78%
102.70
+9.83%
93.50
Gross PPE
225.03
+12.54%
199.95
+5.09%
190.27
+103.48%
93.50
Accumulated Depreciation
-105.97
-9.88%
-96.45
-10.14%
-87.57
-10.97%
-78.91
Properties
0.00
0.00
0.00
0.00
Land And Improvements
48.67
+0.14%
48.60
+1.33%
47.96
+1.69%
47.16
Buildings And Improvements
8.61
+5.36%
8.18
-12.95%
9.39
+15.64%
8.12
Machinery Furniture Equipment
136.42
+8.16%
126.12
+14.08%
110.56
+2.22%
108.16
Construction In Progress
26.53
+111.50%
12.54
-21.39%
15.96
+795.85%
1.78
Other Properties
4.80
+6.45%
4.51
-29.56%
6.41
-93.15%
93.50
Goodwill And Other Intangible Assets
73.36
-1.68%
74.62
-9.03%
82.03
+62.78%
50.39
Goodwill
43.39
+0.54%
43.16
-2.26%
44.15
+135.79%
18.73
Other Intangible Assets
29.97
-4.74%
31.46
-16.93%
37.88
+19.61%
31.67
Investments And Advances
3.99
+6.68%
3.74
-1.50%
3.80
-3.99%
3.96
Long Term Equity Investment
—
—
0.00
0.00
Non Current Accounts Receivable
4.52
+1.19%
4.47
+7.79%
4.14
+2.47%
4.04
Non Current Deferred Assets
3.52
+25.96%
2.80
+135.83%
1.19
+22.52%
0.97
Non Current Deferred Taxes Assets
3.52
+25.96%
2.80
+135.83%
1.19
+422.47%
0.23
Non Current Prepaid Assets
0.42
-14.20%
0.49
+22.03%
0.40
-9.62%
0.45
Other Non Current Assets
0.95
+74.59%
0.54
-7.18%
0.58
+1439.47%
0.04
Total Liabilities Net Minority Interest
147.84
-7.62%
160.04
-12.23%
182.33
+0.83%
180.83
Current Liabilities
102.18
-2.64%
104.95
-1.10%
106.11
+16.05%
91.44
Payables And Accrued Expenses
41.38
+9.39%
37.83
-12.85%
43.40
+20.50%
36.02
Payables
26.23
+8.80%
24.11
-8.98%
26.49
+15.12%
23.01
Accounts Payable
23.35
+10.15%
21.20
-8.76%
23.23
+15.17%
20.17
Current Accrued Expenses
15.14
+10.44%
13.71
-18.91%
16.91
+30.02%
13.01
Total Tax Payable
2.89
-1.03%
2.92
-10.61%
3.26
+14.82%
2.84
Current Debt And Capital Lease Obligation
13.00
-49.00%
25.48
+27.67%
19.96
-5.86%
21.20
Current Debt
10.38
-54.61%
22.87
+34.09%
17.06
-4.43%
17.85
Other Current Borrowings
10.38
-54.61%
22.87
+34.09%
17.06
-4.43%
17.85
Current Capital Lease Obligation
2.61
+0.15%
2.61
-10.06%
2.90
-13.45%
3.35
Current Deferred Liabilities
46.67
+13.61%
41.08
-3.38%
42.52
+26.60%
33.58
Current Deferred Revenue
46.00
+12.77%
40.79
-2.23%
41.72
+25.26%
33.31
Other Current Liabilities
1.13
+101.60%
0.56
+138.14%
0.24
-62.66%
0.63
Total Non Current Liabilities Net Minority Interest
45.67
-17.10%
55.09
-27.73%
76.22
-14.74%
89.39
Long Term Debt And Capital Lease Obligation
28.29
-27.31%
38.91
-36.23%
61.02
-21.67%
77.91
Long Term Debt
23.18
-30.99%
33.58
-39.90%
55.87
-23.08%
72.64
Long Term Capital Lease Obligation
5.11
-4.14%
5.33
+3.61%
5.15
-2.30%
5.27
Long Term Provisions
0.86
-39.65%
1.43
-11.24%
1.61
+141.53%
0.67
Non Current Deferred Liabilities
16.47
+14.17%
14.43
+6.16%
13.59
+25.56%
10.82
Non Current Deferred Revenue
13.27
+23.99%
10.70
+15.35%
9.28
+43.78%
6.45
Non Current Deferred Taxes Liabilities
3.20
-14.04%
3.73
-13.61%
4.31
-1.35%
4.37
Other Non Current Liabilities
0.05
-85.44%
0.32
+31500.00%
0.00
-99.95%
2.17
Stockholders Equity
248.58
+5.04%
236.65
+3.36%
228.96
-1.56%
232.58
Common Stock Equity
248.58
+5.04%
236.65
+3.36%
228.96
-1.56%
232.58
Capital Stock
4.49
+0.00%
4.49
+0.00%
4.49
-0.04%
4.49
Common Stock
4.49
+0.00%
4.49
+0.00%
4.49
-0.04%
4.49
Share Issued
59.07
+0.00%
59.07
+0.00%
59.07
+0.01%
59.06
Ordinary Shares Number
59.07
+0.00%
59.07
+0.00%
59.07
+0.01%
59.06
Additional Paid In Capital
233.90
-0.02%
233.94
+0.02%
233.90
+0.01%
233.87
Retained Earnings
19.00
+241.48%
5.56
+580.48%
-1.16
-220.00%
0.96
Gains Losses Not Affecting Retained Earnings
-8.80
-19.83%
-7.35
+11.15%
-8.27
-22.51%
-6.75
Minority Interest
-0.09
-62.26%
-0.05
-89.29%
-0.03
-2900.00%
0.00
Other Equity Adjustments
-8.80
-19.83%
-7.35
+11.15%
-8.27
-22.51%
-6.75
Total Equity Gross Minority Interest
248.49
+5.03%
236.59
+3.35%
228.93
-1.57%
232.58
Total Capitalization
271.75
+0.56%
270.23
-5.13%
284.83
-6.68%
305.21
Working Capital
88.33
-12.98%
101.52
-7.96%
110.30
-33.70%
166.37
Invested Capital
282.14
-3.74%
293.10
-2.91%
301.89
-6.55%
323.06
Total Debt
41.28
-35.89%
64.40
-20.48%
80.98
-18.29%
99.11
Capital Lease Obligations
7.73
-2.73%
7.94
-1.32%
8.05
-6.63%
8.62
Net Tangible Assets
175.21
+8.14%
162.03
+10.28%
146.93
-19.35%
182.18
Tangible Book Value
175.21
+8.14%
162.03
+10.28%
146.93
-19.35%
182.18
Available For Sale Securities
—
—
0.31
-23.06%
0.40
Duefrom Related Parties Non Current
—
—
—
0.00
Dueto Related Parties Current
—
—
0.00
0.00
Financial Assets Designatedas Fair Value Through Profitor Loss Total
3.99
+6.68%
3.74
+7.16%
3.49
-1.85%
3.56
Investmentin Financial Assets
3.99
+6.68%
3.74
-1.50%
3.80
-3.99%
3.96
Investments In Other Ventures Under Equity Method
—
—
—
0.40
Investmentsin Joint Venturesat Cost
—
—
0.00
0.00
Non Current Note Receivables
—
0.00
0.00
-100.00%
2.25
Other Equity Interest
-0.00
+0.00%
-0.00
+0.00%
-0.00
—
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
31.46
+56.05%
20.16
-9.56%
22.29
-13.76%
25.84
Cash Flow From Continuing Operating Activities
31.46
+56.04%
20.16
-9.55%
22.29
-13.76%
25.84
Net Income From Continuing Operations
13.41
+100.24%
6.70
+410.96%
-2.15
-116.38%
13.14
Depreciation Amortization Depletion
21.76
+0.89%
21.57
-4.43%
22.57
+9.83%
20.55
Depreciation
15.37
+2.04%
15.06
+0.84%
14.94
-4.07%
15.57
Amortization Cash Flow
6.39
-1.77%
6.50
-14.74%
7.63
+53.33%
4.97
Depreciation And Amortization
21.76
+0.89%
21.57
-4.43%
22.57
+9.83%
20.55
Amortization Of Intangibles
6.39
-1.77%
6.50
-14.74%
7.63
+53.33%
4.97
Other Non Cash Items
-4.64
-304.09%
-1.15
+32.17%
-1.69
-11.52%
-1.52
Stock Based Compensation
0.28
+630.77%
0.04
+127.86%
-0.14
+86.49%
-1.04
Provisionand Write Offof Assets
0.78
+143.71%
0.32
-81.91%
1.76
+396.61%
0.35
Asset Impairment Charge
0.05
-98.91%
4.23
0.00
-100.00%
0.18
Deferred Tax
0.71
+878.08%
0.07
-92.51%
0.97
+64.97%
0.59
Deferred Income Tax
0.71
+878.08%
0.07
-92.51%
0.97
+64.97%
0.59
Operating Gains Losses
-0.28
+44.40%
-0.51
-265.26%
0.31
+23.20%
0.25
Net Foreign Currency Exchange Gain Loss
0.03
+130.85%
-0.09
-141.03%
-0.04
-197.50%
0.04
Gain Loss On Sale Of PPE
-0.31
+24.82%
-0.41
-219.60%
0.35
+65.24%
0.21
Change In Working Capital
-1.42
+88.72%
-12.58
-1328.13%
1.02
+117.39%
-5.89
Change In Receivables
-1.04
+68.91%
-3.33
+47.31%
-6.33
+42.03%
-10.92
Changes In Account Receivables
-1.04
+68.91%
-3.33
+47.31%
-6.33
+42.03%
-10.92
Change In Inventory
-0.37
+53.85%
-0.81
+83.92%
-5.01
-252.14%
-1.42
Change In Payables And Accrued Expense
-0.01
+99.89%
-8.44
-168.22%
12.37
+91.62%
6.45
Change In Payable
-0.01
+99.89%
-8.44
-168.22%
12.37
+91.62%
6.45
Change In Account Payable
—
—
—
6.45
Investing Cash Flow
-28.59
-159.02%
-11.04
+79.51%
-53.86
-310.09%
-13.13
Cash Flow From Continuing Investing Activities
-28.59
-159.03%
-11.04
+79.51%
-53.86
-310.09%
-13.13
Net PPE Purchase And Sale
-24.19
-184.20%
-8.51
+60.23%
-21.40
-186.44%
-7.47
Purchase Of PPE
-24.65
-166.91%
-9.23
+57.26%
-21.61
-172.35%
-7.93
Sale Of PPE
0.46
-36.65%
0.72
+252.68%
0.20
-55.63%
0.46
Capital Expenditure
-26.38
-124.29%
-11.76
+52.53%
-24.77
-111.34%
-11.72
Net Investment Purchase And Sale
—
—
—
0.00
Purchase Of Investment
—
—
—
0.00
Net Business Purchase And Sale
-2.67
0.00
+100.00%
-29.29
-3247.77%
-0.88
Purchase Of Business
-2.67
0.00
+100.00%
-29.29
-3247.77%
-0.88
Net Intangibles Purchase And Sale
-1.73
+31.56%
-2.52
+20.22%
-3.17
+16.45%
-3.79
Purchase Of Intangibles
-1.73
+31.56%
-2.52
+20.22%
-3.17
+16.45%
-3.79
Net Other Investing Changes
0.00
—
—
-1.00
Financing Cash Flow
-27.64
-23.59%
-22.37
+0.63%
-22.51
-131.63%
71.16
Cash Flow From Continuing Financing Activities
-27.64
-23.59%
-22.37
+0.63%
-22.51
-131.63%
71.16
Net Issuance Payments Of Debt
-26.39
-30.17%
-20.27
+3.86%
-21.09
-16.81%
-18.05
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
-26.39
-30.17%
-20.27
+3.86%
-21.09
-16.81%
-18.05
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
-26.39
-30.17%
-20.27
+3.86%
-21.09
-16.81%
-18.05
Net Long Term Debt Issuance
-26.39
-30.17%
-20.27
+3.86%
-21.09
-16.81%
-18.05
Net Common Stock Issuance
0.00
0.00
-100.00%
0.02
-99.97%
88.12
Cash Dividends Paid
0.00
0.00
0.00
0.00
Proceeds From Stock Option Exercised
—
—
—
88.12
Net Other Financing Charges
0.08
+123.70%
-0.35
-163.60%
0.54
-84.08%
3.42
Changes In Cash
-24.78
-87.02%
-13.25
+75.50%
-54.08
-164.49%
83.87
Effect Of Exchange Rate Changes
-0.49
-969.57%
-0.05
+95.73%
-1.08
-272.76%
0.62
Beginning Cash Position
127.57
-9.44%
140.87
-28.14%
196.03
+75.75%
111.54
End Cash Position
102.30
-19.81%
127.57
-9.44%
140.87
-28.14%
196.03
Free Cash Flow
5.08
-39.51%
8.40
+437.91%
-2.48
-117.60%
14.12
Common Stock Issuance
0.00
0.00
-100.00%
0.02
-99.97%
88.12
Earnings Losses From Equity Investments
—
0.00
0.00
0.00
Interest Paid CFF
-1.34
+23.60%
-1.75
+12.06%
-1.99
+14.45%
-2.33
Interest Received CFI
—
—
—
0.00
Interest Received CFO
3.96
-5.73%
4.21
+294.19%
1.07
+183.78%
0.38
Issuance Of Capital Stock
0.00
0.00
-100.00%
0.02
-99.97%
88.12
Taxes Refund Paid
-3.15
-15.16%
-2.74
-92.07%
-1.43
-23.70%
-1.15
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category